Schizophrenia.com
Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised controlled comparison with simvastatin
News
everhopeful
September 5, 2024, 12:21pm
1
1 Like
Related topics
Topic
Replies
Views
Activity
Adjunctive ondansetron for schizophrenia: A systematic review and meta-analysis of randomized controlled trials
News
0
247
March 18, 2019
Zofran against negative symptoms & tardive dyskinesia
Medications
2
1789
February 19, 2016
Ondansetron - a promising adjunctive treatment for persistent schizophrenia
News
1
368
October 26, 2018
Anti - Inflammatories may cut Negative Symptoms of Schizophrenia
News
3
714
April 12, 2015
Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial
News
8
988
March 16, 2017